Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LCEP4 (Late Cornified Envelope Pseudogene 4) is an annotated pseudogene in the human epidermal differentiation complex (EDC) on chromosome 1q21. It is structurally related to the small proline-rich protein family and late envelope proteins (LEPs), which are incorporated late during the maturation of the epidermal cornified envelope to support barrier function in differentiated keratinocytes. Unlike functional late envelope protein genes, LCEP4 is considered a pseudogene and does not encode a known functional protein. Although some pseudogenes are now recognized for their regulatory potential—for example, through the generation of long noncoding RNAs (lncRNAs) that modulate the expression of other genes—the specific biological role and regulatory impact of LCEP4 have not been demonstrated. LCEP4 is not considered a therapeutic target, biomarker, or molecule implicated in disease causation, and no drugs or mechanisms of action are known to interact with it. Summary of key points: - LCEP4 is a pseudogene, not a protein-coding gene, and not a receptor, enzyme, transporter, or drug target. - Its function, if any, is likely limited to potential noncoding RNA regulatory activities typical of pseudogenes, but this is unconfirmed in the case of LCEP4. - No disease association, drug interactions, or biomarker use for LCEP4 have been reported. - LCEP4 is not a canonical or actionable target in biomedical research or therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Late Cornified Envelope Pseudogene 4 (LCEP4).